Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
26 September 2019 | Story Ruan Bruwer | Photo Supplied
Kovsies Women Cross-Country Team Marné Mentz, Vicky Oelofse, and Channah du Plessis
Marné Mentz, Ts’epang Sello, and Tyler Beling played a huge role in Kovsies' cross-country champions win.

After coming within a whisker of claiming the title in 2018, the University of the Free State’s (UFS) runners ensured that the University Sports South Africa (USSA) cross-country trophy comes to Bloemfontein in 2019.

Kovsies are the new national student cross-country champions after they (men and women combined) won the USSA Championships in Nelspruit on Saturday, 21 September. Kovsies and the University of Johannesburg (UJ) both finished with three gold medals at the same event in 2018. UJ finished with nine overall medals compared to the eight (three gold, two silver, and three silver) of the UFS, who had to settle for second place. In 2017, the UFS finished third.

The Kovsie women’s team played a huge role in carrying the team to the top of the medal table, winning four golds. They won the 4 km and 10 km women’s team competitions as well as the road relay. The top three places by the runners of a university determined the team winner.

Marné Mentz UFS Cross-Country

Marné Mentz’s gold medal in the four-kilometre race at the
USSA Cross Country Championships helped the Kovsies
win the overall title.

Marné Mentz (first), Vicky Oelofse (fifth), and Channah du Plessis (sixth) dominated the four-kilometre race. In the 10 km, Ts’epang Sello (third), Tyler Beling (sixth), and Lizandré Mulder (seventh) did enough to ensure another gold for the Free State students. Mentz, Sello, and Beling jointly took first place in the road relay.

In the 10-km race for men, Kovsies came fifth, with Victor Makhabesela the best performer (finishing ninth). Pakiso Mthembu, one of the contenders for the medal who won the silver medal at the National Cross Country Championships two weeks before, had to withdraw after 7 km in the race due to an injury.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept